BioHarvest Sciences Basic EPS 2020-2024 | BHST
BioHarvest Sciences basic eps from 2020 to 2024. Basic eps can be defined as a company's net earnings or losses attributable to common shareholders per basic share basis.
| BioHarvest Sciences Annual Basic EPS |
| 2023 |
$-1.05 |
| 2022 |
$-0.70 |
| 2021 |
$-0.70 |
| 2020 |
$-0.70 |
| 2019 |
$1.75 |
| 2019 |
$-3.15 |
| 2018 |
$ |
| BioHarvest Sciences Quarterly Basic EPS |
| 2024-06-30 |
$-0.04 |
| 2024-03-31 |
$-0.35 |
| 2023-12-31 |
$-0.84 |
| 2023-09-30 |
$0.00 |
| 2023-06-30 |
$-0.21 |
| 2023-03-31 |
$0.00 |
| 2022-12-31 |
$-0.70 |
| 2022-09-30 |
$0.35 |
| 2022-06-30 |
$-0.35 |
| 2022-03-31 |
$0.00 |
| 2021-12-31 |
$-1.05 |
| 2021-09-30 |
$-0.35 |
| 2021-06-30 |
$0.00 |
| 2021-03-31 |
$0.70 |
| 2020-12-31 |
|
| 2020-09-30 |
$0.00 |
| 2020-06-30 |
$0.00 |
| 2020-03-31 |
$0.00 |
| 2019-12-31 |
|
| 2019-09-30 |
$0.00 |
| 2019-06-30 |
$0.00 |
| 2019-03-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.098B |
$0.013B |
|
BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.
|
